1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Series A Preferred Stock
|
Â
(1)
|
Â
(1)
|
Common Stock
|
1,000,000
|
$
(1)
|
I
|
See Footnote
(2)
|
Series C Preferred Stock
|
Â
(3)
|
Â
(3)
|
Common Stock
|
200,000
|
$
(3)
|
I
|
See Footnote
(2)
|
Stock Option (right to buy)
|
Â
(4)
|
01/25/2017 |
Common Stock
|
9,583
|
$
13.04
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(5)
|
01/25/2017 |
Common Stock
|
1,150
|
$
13.04
|
D
|
Â
|
Common Stock Warrant (right to buy)
|
05/30/2006 |
04/28/2016 |
Common Stock
|
15,352
|
$
13.04
|
I
|
See Footnote
(2)
|
Common Stock Warrant (right to buy)
|
03/31/2008 |
03/31/2018 |
Common Stock
|
1,917
|
$
20.66
|
I
|
See Footnote
(2)
|
Common Stock Warrant (right to buy)
|
12/30/2009 |
12/30/2019 |
Common Stock
|
7,099
|
$
(6)
|
I
|
See Footnote
(2)
|
Common Stock Warrant (right to buy)
|
10/05/2010 |
10/05/2020 |
Common Stock
|
7,099
|
$
(6)
|
I
|
See Footnote
(2)
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
The Series A Convertible Preferred Stock is convertible, at any time at the holders election, into the Issuer's common stock at a ratio of approximately 1:0.0958 and has no expiration date. |
(2) |
Held by Malcolm McQuilkin Living Trust of which Malcolm McQuilkin is a co-trustee. |
(3) |
The Series C Convertible Preferred Stock is convertible, at any time at the holders election, into the Issuer's common stock at a ratio of approximately 1:0.184 and has no expiration date. |
(4) |
7,187 of these options are vested and exercisable. The remaining 2,396 options will vest on January 25, 2011 or upon the consummation of an initial public offering. |
(5) |
All of these shares are fully vested and exercisable. |
(6) |
The exercise price of these warrants is $13.04 or, after an initial public offering of the Issuer resulting in aggregate proceeds to the Issuer of an amount greater than $30.0 million, 80% of the initial public offering price per share. |